Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Brain Dopamine Function in Adults With ADHD (Brookhaven)

This study has been completed.
Sponsor:
Collaborators:
Icahn School of Medicine at Mount Sinai
Duke University
Information provided by:
University of California, Irvine
ClinicalTrials.gov Identifier:
NCT00580814
First received: October 4, 2007
Last updated: April 6, 2011
Last verified: April 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2009
  Primary Completion Date: March 2009 (Final data collection date for primary outcome measure)
Publications:
Volkow, N.d., Wand, G., Kollins., Wigal, T., Newcorn, J., Telang, F., Fowler, J., Solanto, M.V., Logan, J., Ma, Y., Pradham. K., Wong, C., Zhu, W. & Swanson, J.M. Dopamine Reward Pathway Disrupted in Patients with ADHD: Therapeutic Implications, Journal of American Medical Association.